Search Results - "GENELL, Anna"

Bias in odds ratios by logistic regression modelling and sample size by Nemes, Szilard, Jonasson, Junmei Miao, Genell, Anna, Steineck, Gunnar

“…In epidemiological studies researchers use logistic regression as an analytical tool to study the association of a binary outcome to a set of possible…”
Get full text

Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry by Blimark, Cecilie Hveding, Turesson, Ingemar, Genell, Anna, Ahlberg, Lucia, Björkstrand, Bo, Carlson, Kristina, Forsberg, Karin, Juliusson, Gunnar, Linder, Olle, Mellqvist, Ulf-Henrik, Nahi, Hareth, Kristinsson, Sigurdur Y

“…Epidemiology and outcome of myeloma are mainly reported from large university centers and collaborative groups, and do not represent 'real-world' patients. The…”
Get full text

Improved survival in myeloma patients-a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden by Moore, Kari Lenita Falck, Turesson, Ingemar, Genell, Anna, Klausen, Tobias W, Knut-Bojanowska, Dorota, Redder, Louise, Sverrisdottir, Ingigerdur, Thorsen, Jonathan, Vangsted, Annette J, Blimark, Cecilie H

“…The prevalence of multiple myeloma (MM) is increasing in Nordic countries and the rest of the western world. Patients aged ≥75 years at diagnosis constitute an…”
Get full text

Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population‐based data from the Swedish Myeloma Register by Nahi, Hareth, Genell, Anna, Wålinder, Göran, Uttervall, Katarina, Juliusson, Gunnar, Karin, Forsberg, Hansson, Markus, Svensson, Ronald, Linder, Olle, Carlson, Kristina, Björkstrand, Bo, Kristinsson, Sigurdur Y., Mellqvist, Ulf Henrik, Blimark, Cecilie, Turesson, Ingemar

“…Solitary plasmacytoma (SP) and plasma cell leukemia (PCL) are uncommon (3‐6%) types of plasma cell disease. The risk of progression to symptomatic multiple…”
Get full text

Model selection in medical research: a simulation study comparing Bayesian model averaging and stepwise regression by Genell, Anna, Nemes, Szilard, Steineck, Gunnar, Dickman, Paul W

“…Automatic variable selection methods are usually discouraged in medical research although we believe they might be valuable for studies where subject matter…”
Get full text

Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study by Wålinder, Göran, Genell, Anna, Juliusson, Gunnar, Svensson, Ronald, Santamaria, Antonio Izarra, Crafoord, Jacob, Carlson, Kristina, Knut‐Bojanowska, Dorota, Veskovski, Ljupco, Lauri, Birgitta, Lund, Johan, Turesson, Ingemar, Hansson, Markus, Blimark, Cecilie Hveding, Nahi, Hareth

“…Background We wanted to evaluate if health care for multiple myeloma (MM) patients is equal in different regions of Sweden. Aim To study differences in…”
Get full text

Exploring the meaning, role and experiences of a patient-led social innovation for people affected by cancer: a new collaborative care model complementing traditional cancer rehabilitation in Sweden by Smith, Frida, Hellström, Andreas, Gunnarsdóttir, Katrín Ásta, Genell, Anna, Eriksson, Erik, Mannefred, Carina, Björk-Eriksson, Thomas, Vaughn, Lisa

“…ObjectiveKraftens Hus is the first support centre in Sweden designed by and for people affected by cancer, including patients, family, friends, staff members…”
Get full text

Usefulness of Current Risk Groups in the Treatment of Surgically Staged Endometrial Carcinomas; A Population-based Study from Western Sweden by PAULSSON, Gunnar, GENELL, Anna, JAKOBSEN, Anne-Marie, HORVATH, György

“…Background: Endometrial carcinoma is the most common malignancy of the female genital tract and its incidence is increasing. However, treatment results have…”
Get full text

Improved survival in myeloma patients- a nationwide registry study of 4647 patients ≥75 years treated in Denmark and Sweden by Moore, Kari Lenita Falck, Turesson, Ingemar, Genell, Anna, Klausen, Tobias Wirenfeldt, Dorota Knut-Bojanowska, Knut-Bojanowska, Redder, Louise, Sverrisdottir, Ingigerdur, Thorsen, Jonathan, Vangsted, Annette Juul, Blimark, Cecilie Hveding

“…The prevalence of multiple myeloma (MM) is increasing in the Nordic countries and the rest of the Western World. Patients aged ≥75 years at diagnosis…”
Get full text

Upfront Autologous Stem Cell Transplantation in Myeloma Patients >65 Years: A Population-Based Study from the Nordic Myeloma Study Group by Moore, Kari Lenita Falck, Genell, Anna, Kaare, Ain, Knut-Bojanowska, Dorota, Loigom, Diana, Lysen, Anna, Nordberg Nørgaard, Jakob, Palk, Katrin, Pärnat, Maris, Peceliunas, Valdas, Rögnvaldsson, Sæmundur, Schjesvold, Fredrik, Sigurdsson, Alexander, Szabo, Agoston Gyula, Thorsen, Jonathan, Thorsteinsdottir, Sigrun, Vaitekėnaitė, Vilmantė, Vangsted, Annette J., Blimark, Cecilie Hveding

“…Background Current guidelines recommend upfront autologous stem cell transplantation (ASCT) as part of first line treatment of newly diagnosed multiple myeloma…”
Get full text

P-167: Real-world elderly myeloma patients: improved survival despite more adverse risk factors than younger patients and RCT populations. A study on behalf of the Nordic Myeloma Study Group by Moore, Kari Lenita Falck, Blimark, Cecilie Hveding, Vangsted, Annette Juul, Turesson, Ingemar, Klausen, Tobias, Redder, Louise, Knut-Bojanowska, Dorota, Sverrisdottir, Ingigerdur, Genell, Anna

“…Elderly multiple myeloma (MM) patients are underrepresented in randomized clinical trials (RCTs). Prospective registries provide insight into real-world…”
Get full text

P-184: Regional differences in treatment and outcome for myeloma patients in Sweden: a population based Swedish Myeloma Register study by Wålinder, Göran, Genell, Anna, Juliusson, Gunnar, Svensson, Ronald, Santamaria, Antonio, Crafoord, Jacob, Carlson, Kristina, Knut-Bojanowska, Dorota, Veskovski, Ljupco, Lauri, Birgitta, Lund, Johan, Turesson, Ingemar, Hansson, Markus, Blimark, Cecilie Hveding, Nahi, Hareth

“…The objective of this study was to investigate if there are differences in survival for Multiple myeloma (MM) patients in Sweden depending on health care…”
Get full text

Evaluating the implementation and use of the regional cancer plan in Western Sweden through concept mapping by Smith, Frida, Gunnarsdóttir, Katrín Ásta, Genell, Anna, McLinden, Daniel, Vaughn, Lisa, Garelius, Hege, Nilsson-Ehle, Herman, Lönqvist, Ulf, Björk-Eriksson, Thomas

“…Abstract Quality problem or issue Within healthcare, policy documents are often used to strategically standardize, streamline or change how general health…”
Get full text

Over 10 years relative median survival in MM patients ≤ 65 years with VGPR or better on 1st line treatment. Population-based data on patients diagnosed 2008-2018 from the Swedish Myeloma Registry by Blimark, Cecilie Hveding, Genell, Anna, Lund, Johan, Nahi, Hareth, Carlson, Kristina, Forsberg, Karin, Juliusson, Gunnar, Lauri, Birgitta, Linder, Olle, Danielsson, Signe, Svensson, Ronald, Vesskovski, Ljupco, Knut-Bojanowska, Dorota, Turesson, Ingemar

Get full text